In a report released today, Matt Larew from William Blair maintained a Hold rating on Amedisys (AMED – Research Report). The company’s shares ...

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street ...

Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

(2) Adjusted EBITDA is defined as net income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain items as ...

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

Reports Q1 revenue $594.8M, consensus $596.49M.Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score ...

(RTTNews) - Amedisys (AMED) announced earnings for its first quarter that increased from the same period last year and beat the Street estimates. The company's bottom line totaled $61.01 million ...

Amedisys (AMED) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.03 per share a year ago. These figures are ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported first-quarter earnings of $61 million. On a per-share basis, the Baton Rouge, Louisiana-based company ...